Hunger hormone levels in blood may reveal dementia type

NCT ID NCT05381090

Completed Knowledge-focused Sponsor: Swansea University Source: ClinicalTrials.gov ↗

First seen Jul 08, 2026 · Last updated Jul 09, 2026 · Updated 1 time

Summary

This study investigates whether levels of the hormone ghrelin in the blood differ between people with various types of dementia, including Alzheimer's disease and dementia with Lewy bodies. Researchers will collect blood samples from 85 participants over age 60, both fasting and after eating, to measure ghrelin and related markers. The goal is to see if these measurements can help identify or distinguish different forms of dementia.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to a simple blood test to help diagnose or distinguish different types of dementia earlier.
What could go wrong: This is a small, early-stage study that only measures biomarkers, not a treatment. The findings may not translate into a reliable diagnostic test.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Alzheimer disease dementia Lewy body dementia Parkinson disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DEMENTIA

Contacts and locations

Show contact details

Locations

Swansea University

Swansea, sa2 8pp, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.